Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

Purdue researchers were awarded the Presidential Early Career Award for Scientists and Engineers by the U.S. government ...

Structure Therapeutics, Inc. Sponsored ADR (GPCR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst ...

Novo Nordisk A/S soared the most since August 2023 after an experimental shot delivered as much as 22% weight loss in an early-stage trial, boosting investors’ hopes for the drugmaker’s pipeline.

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

With the recent surge in popularity of weight loss drugs like Ozempic, altogether called GLP-1s, there has been renewed scientific interest in understanding how our bodies regulate muscle growth.

Wegovy and Ozempic have become household names, but how easy are they to get if you don't meet the medical criteria? Sky's Lucy Marley went to find out.

Semaglutide (known by its brandname Ozempic) has gained widespread attention for its weight loss benefits, but is officially approved for managing type 2 diabetes. While there is currently limited ...

Danish multinational pharmaceutical giant Novo Nordisk is the sole owner of semaglutide, the active ingredient in both Ozempic and Wegovy ... and would be able to structure them as specifically ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

No, it’s not ‘brat’, ‘demure’, or even ‘brain rot’; it’s Ozempic. The drug has become increasingly popular for helping people (including your favourite celebrities) lose weight ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...